Abstract
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have